X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1937) 1937
Publication (191) 191
Book / eBook (24) 24
Book Review (20) 20
Book Chapter (8) 8
Conference Proceeding (4) 4
Newsletter (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (1632) 1632
humans (1574) 1574
index medicus (961) 961
obstetrics & gynecology (908) 908
adult (883) 883
pregnancy (783) 783
reproductive biology (713) 713
endocrinology & metabolism (662) 662
in-vitro fertilization (501) 501
ovarian hyperstimulation syndrome (485) 485
women (404) 404
fertilization in vitro (369) 369
ovulation induction - methods (344) 344
animals (340) 340
ovulation induction (337) 337
ivf (288) 288
follicle-stimulating-hormone (277) 277
pregnancy rate (273) 273
obstetrics and gynecology (257) 257
ovarian stimulation (254) 254
infertility (229) 229
developmental biology (218) 218
human chorionic-gonadotropin (204) 204
in vitro fertilization (201) 201
endocrinology (189) 189
estradiol - blood (188) 188
fertilization in vitro - methods (180) 180
research (179) 179
treatment outcome (177) 177
medicine & public health (175) 175
male (173) 173
expression (169) 169
retrospective studies (166) 166
prospective studies (164) 164
luteinizing-hormone (163) 163
endothelial growth-factor (160) 160
anti-mullerian hormone (159) 159
gonadotropin-releasing hormone - antagonists & inhibitors (159) 159
internal medicine (158) 158
endocrine system (155) 155
infertility, female - therapy (155) 155
embryo transfer (153) 153
gynecology (150) 150
ovulation (150) 150
polycystic ovary syndrome (149) 149
analysis (145) 145
gonadotropin-releasing hormone - agonists (144) 144
ovarian hyperstimulation syndrome - metabolism (144) 144
ovarian hyperstimulation syndrome - prevention & control (140) 140
ovary - metabolism (140) 140
young adult (134) 134
ovulation induction - adverse effects (133) 133
reproductive medicine (133) 133
controlled ovarian hyperstimulation (126) 126
ovarian follicle - metabolism (126) 126
stimulation (125) 125
ovarian follicle - drug effects (124) 124
reproduction (124) 124
assisted reproduction (121) 121
follicular fluid - metabolism (121) 121
ovary - drug effects (121) 121
follicle-stimulating hormone (120) 120
ovarian cancer (120) 120
risk factors (120) 120
genetics & heredity (119) 119
gonadotropin (119) 119
human genetics (118) 118
invitro fertilization (115) 115
oocytes (115) 115
fertilization (113) 113
stein-leventhal syndrome (112) 112
ovarian hyperstimulation syndrome - etiology (111) 111
estradiol (107) 107
ohss (106) 106
hormones (105) 105
pregnancy outcome (105) 105
follicle stimulating hormone - blood (102) 102
mice (102) 102
progesterone (102) 102
ovarian follicle - physiology (101) 101
gnrh antagonist (99) 99
fsh (97) 97
vascular endothelial growth factor (97) 97
health aspects (96) 96
physiological aspects (96) 96
cycles (95) 95
gynecology and obstetrics (95) 95
ovarian reserve (95) 95
gonadotropin-releasing hormone - analogs & derivatives (94) 94
gonadotropins (94) 94
luteinizing hormone - blood (94) 94
sperm injections, intracytoplasmic (94) 94
progesterone - blood (93) 93
cell biology (91) 91
granulosa cells - metabolism (91) 91
oocyte retrieval (91) 91
in-vitro (90) 90
assisted reproductive technology (89) 89
chorionic gonadotropin - administration & dosage (89) 89
chorionic gonadotropin - pharmacology (89) 89
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1944) 1944
French (8) 8
Chinese (7) 7
Spanish (3) 3
Czech (2) 2
Danish (2) 2
German (2) 2
Japanese (2) 2
Bulgarian (1) 1
Korean (1) 1
Norwegian (1) 1
Portuguese (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Obstetrics and Gynecology, ISSN 0002-9378, 2016, Volume 216, Issue 1, pp. 42.e1 - 42.e10
Background Ovarian hyperstimulation syndrome is an iatrogenic complication of controlled ovarian stimulation. Early ovarian hyperstimulation syndrome occurs... 
Obstetrics and Gynecology | letrozole | ovarian hyperstimulation syndrome | aspirin | in vitro fertilization | vascular endothelial growth factor | LUTEAL-PHASE | PERMEABILITY | PREVENTION | SUPPRESSION | ovarian hyperstimulation | OBSTETRICS & GYNECOLOGY | OOCYTE RETRIEVAL | LOW-DOSE ASPIRIN | SYNDROME OHSS | syndrome | in vitro fertilization | IN-VITRO FERTILIZATION | ENDOTHELIAL GROWTH-FACTOR | Severity of Illness Index | Estradiol - metabolism | Ascites - etiology | Primary Prevention | Risk Assessment | Ovarian Hyperstimulation Syndrome - complications | Humans | Ovarian Hyperstimulation Syndrome - diagnostic imaging | Ascites - diagnostic imaging | Ovarian Hyperstimulation Syndrome - metabolism | Vascular Endothelial Growth Factor A - metabolism | Reproductive Control Agents - therapeutic use | Chorionic Gonadotropin - therapeutic use | Luteal Phase | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Ovulation Induction - methods | Ovarian Hyperstimulation Syndrome - prevention & control | Adult | Female | Aspirin - therapeutic use | Aromatase Inhibitors - therapeutic use | Oocyte Retrieval - methods | Nitriles - therapeutic use | Triazoles - therapeutic use | Antimitotic agents | Chorionic gonadotropin | Endothelial growth factors | Glycoproteins | Permeability | Antineoplastic agents | Endothelium
Journal Article
Human Reproduction Update, ISSN 1355-4786, 2008, Volume 14, Issue 4, pp. 321 - 333
BACKGROUND Ovarian hyperstimulation syndrome (OHSS) typically occurs when ovaries are primed with FSH/LH and subsequently exposed to hCG. The ultimate... 
Ovarian hyperstimulation syndrome | Pathophysiology | Vascular endothelial growth factor | Vascular permeability | Dopamine agonist | HUMAN GRANULOSA-CELLS | FACTOR VEGF | ovarian hyperstimulation syndrome | PERMEABILITY FACTOR | DOPAMINE AGONIST CABERGOLINE | FACTOR RECEPTOR-1 | dopamine agonist | CORPORA-LUTEA | HUMAN CHORIONIC-GONADOTROPIN | LUTEINIZING-HORMONE | OBSTETRICS & GYNECOLOGY | REPRODUCTIVE BIOLOGY | vascular endothelial growth factor | pathophysiology | FOLLICLE-STIMULATING-HORMONE | IN-VITRO FERTILIZATION | vascular permeability | Estrogens - pharmacology | Humans | Dopamine Agonists - therapeutic use | Capillary Permeability - drug effects | Ovarian Hyperstimulation Syndrome - metabolism | Reproductive Control Agents - therapeutic use | Vascular Endothelial Growth Factors - physiology | Chorionic Gonadotropin - pharmacology | Estrogens - therapeutic use | Actin Cytoskeleton - drug effects | Ovarian Hyperstimulation Syndrome - prevention & control | Female | Phosphorylation - drug effects | Pyrroles - therapeutic use | Reproductive Control Agents - pharmacology | Estradiol - pharmacology | Estradiol - therapeutic use | Cells, Cultured | Rats | Clinical Trials as Topic | Chorionic Gonadotropin - therapeutic use | Ergolines - therapeutic use | Animals | Signal Transduction - drug effects | Indoles - therapeutic use | Vascular Endothelial Growth Factors - metabolism | Actin Cytoskeleton - ultrastructure
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 03/2013, Volume 98, Issue 3, pp. E472 - E484
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2016, Volume 11, Issue 3, p. e0149615
Study Question What is the threshold for the prediction of moderate to severe or severe ovarian hyperstimulation syndrome (OHSS) based on the number of growing... 
OOCYTE MATURATION | WOMEN | STIMULATION | METAANALYSIS | MULTIDISCIPLINARY SCIENCES | POLYCYSTIC OVARIES | IVF | PREVENTION | IN-VITRO FERTILIZATION | RECOMBINANT FSH | OHSS | Prognosis | Humans | Ovarian Hyperstimulation Syndrome - metabolism | Follicle Stimulating Hormone, Human - adverse effects | Chorionic Gonadotropin - pharmacology | Young Adult | Ovarian Follicle - drug effects | Adult | Female | Retrospective Studies | Ovulation Induction - adverse effects | Estradiol - metabolism | Follicle Stimulating Hormone, Human - pharmacology | Ovarian Follicle - growth & development | Clinical Trials as Topic | Gonadotropin-Releasing Hormone - antagonists & inhibitors | Ovarian Hyperstimulation Syndrome - pathology | Hormone Antagonists - pharmacology | Pregnancy | Ovarian Hyperstimulation Syndrome - chemically induced | Organ Size - drug effects | Chorionic Gonadotropin - adverse effects | Adolescent | Ovarian Hyperstimulation Syndrome - diagnosis | Hormone Antagonists - adverse effects | Glycoproteins | Chorionic gonadotropin | Hormones | Analysis | Estrogen | In vitro fertilization | Reproductive health | Clinical trials | Ovarian hyperstimulation syndrome | Risk | Stimulation | Systematic review | Follicles | Estradiol | Data bases | Body mass index | Drug dosages | Recombinant | Polycystic ovary syndrome | Fertilization | Maturation | Data processing | Pituitary (anterior) | Gonadotropins | Patients | Sex hormones | Sensitivity | Predictions | Gonadotropin-releasing hormone | Clinical medicine | Coasting
Journal Article
Journal Article
Fertility and Sterility, ISSN 0015-0282, 2011, Volume 95, Issue 2, pp. 673 - 678
Objective To assess the predictive value of endocrine gland–derived vascular endothelial growth factor (EG-VEGF) concentrations in follicular fluid (FF) and... 
Internal Medicine | Obstetrics and Gynecology | ovarian hyperstimulation syndrome | Endocrine gland–derived vascular endothelial growth factor | controlled ovarian hyperstimulation | vascular endothelial growth factor | ovarian response | Endocrine gland-derived vascular endothelial growth factor | FACTOR VEGF | EG-VEGF | ANGIOGENESIS | BV8 | OBSTETRICS & GYNECOLOGY | REPRODUCTIVE BIOLOGY | SYNDROME OHSS | IN-VIVO | PROKINETICINS | RECEPTORS | EXPRESSION | CORPUS-LUTEUM | Ovarian Hyperstimulation Syndrome - etiology | Prognosis | Vascular Endothelial Growth Factor, Endocrine-Gland-Derived - blood | Humans | Vascular Endothelial Growth Factor, Endocrine-Gland-Derived - metabolism | Follicular Fluid - metabolism | Ovarian Hyperstimulation Syndrome - blood | Ovarian Hyperstimulation Syndrome - metabolism | Case-Control Studies | Follicular Fluid - chemistry | Pregnancy | Young Adult | Osmolar Concentration | Embryo Transfer | Ovulation Induction - methods | Fertilization in Vitro - methods | Vascular Endothelial Growth Factor, Endocrine-Gland-Derived - analysis | Adult | Female | Retrospective Studies | Ovarian Hyperstimulation Syndrome - diagnosis | Infertility - therapy | Ovulation Induction - adverse effects | Serum - chemistry | Medicine, Experimental | Medical research | Contraceptives | Vascular endothelial growth factor
Journal Article